NM_173477.5:c.388A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_173477.5(USH1G):​c.388A>G​(p.Lys130Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00695 in 1,613,660 control chromosomes in the GnomAD database, including 612 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K130T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.037 ( 304 hom., cov: 33)
Exomes 𝑓: 0.0039 ( 308 hom. )

Consequence

USH1G
NM_173477.5 missense

Scores

1
7
7

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 5.10

Publications

13 publications found
Variant links:
Genes affected
USH1G (HGNC:16356): (USH1 protein network component sans) This gene encodes a protein that contains three ankyrin domains, a class I PDZ-binding motif and a sterile alpha motif. The encoded protein interacts with harmonin, which is associated with Usher syndrome type 1C. This protein plays a role in the development and maintenance of the auditory and visual systems and functions in the cohesion of hair bundles formed by inner ear sensory cells. Mutations in this gene are associated with Usher syndrome type 1G (USH1G). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
USH1G Gene-Disease associations (from GenCC):
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Usher syndrome type 1G
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002067238).
BP6
Variant 17-74920448-T-C is Benign according to our data. Variant chr17-74920448-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 48130.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.123 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USH1GNM_173477.5 linkc.388A>G p.Lys130Glu missense_variant Exon 2 of 3 ENST00000614341.5 NP_775748.2
USH1GNM_001282489.3 linkc.79A>G p.Lys27Glu missense_variant Exon 2 of 3 NP_001269418.1 Q495M9B4DL95
USH1GXM_011524296.2 linkc.79A>G p.Lys27Glu missense_variant Exon 2 of 3 XP_011522598.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USH1GENST00000614341.5 linkc.388A>G p.Lys130Glu missense_variant Exon 2 of 3 1 NM_173477.5 ENSP00000480279.1 Q495M9
USH1GENST00000579243.1 linkn.335A>G non_coding_transcript_exon_variant Exon 2 of 3 2 ENSP00000462568.1 J3KSN5

Frequencies

GnomAD3 genomes
AF:
0.0365
AC:
5553
AN:
152130
Hom.:
303
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.126
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0143
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.0321
GnomAD2 exomes
AF:
0.00993
AC:
2489
AN:
250576
AF XY:
0.00732
show subpopulations
Gnomad AFR exome
AF:
0.133
Gnomad AMR exome
AF:
0.00697
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000469
Gnomad OTH exome
AF:
0.00506
GnomAD4 exome
AF:
0.00387
AC:
5649
AN:
1461412
Hom.:
308
Cov.:
42
AF XY:
0.00341
AC XY:
2478
AN XY:
727014
show subpopulations
African (AFR)
AF:
0.133
AC:
4458
AN:
33480
American (AMR)
AF:
0.00832
AC:
372
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.000267
AC:
23
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52954
Middle Eastern (MID)
AF:
0.00763
AC:
44
AN:
5768
European-Non Finnish (NFE)
AF:
0.000201
AC:
223
AN:
1112006
Other (OTH)
AF:
0.00874
AC:
528
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
424
848
1271
1695
2119
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
142
284
426
568
710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0365
AC:
5559
AN:
152248
Hom.:
304
Cov.:
33
AF XY:
0.0356
AC XY:
2652
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.126
AC:
5241
AN:
41542
American (AMR)
AF:
0.0142
AC:
217
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.000353
AC:
24
AN:
68016
Other (OTH)
AF:
0.0318
AC:
67
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
259
518
776
1035
1294
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0132
Hom.:
354
Bravo
AF:
0.0429
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.133
AC:
585
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.0117
AC:
1420
EpiCase
AF:
0.000382
EpiControl
AF:
0.000533

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 12, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 20, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 25404053, 25528277, 17896313, 30245029) -

Apr 11, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome type 1G Benign:3
May 13, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 06, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:2
Sep 25, 2011
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Lys130Glu in exon 2 of USH1G: This variant is not expected to have clinical sign ificance because it has been identified with a frequency greater than 5% in cont rols (rs111033465). -

Dec 10, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.79
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.35
CADD
Uncertain
25
DANN
Benign
0.60
DEOGEN2
Uncertain
0.46
T
Eigen
Uncertain
0.26
Eigen_PC
Benign
0.13
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.95
D
MetaRNN
Benign
0.0021
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
5.1
PrimateAI
Uncertain
0.69
T
Sift4G
Uncertain
0.0040
D
Polyphen
1.0
D
Vest4
0.25
ClinPred
0.060
T
GERP RS
2.7
Varity_R
0.71
gMVP
0.71
Mutation Taster
=57/43
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111033465; hg19: chr17-72916543; COSMIC: COSV58882079; COSMIC: COSV58882079; API